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To the Editor: 
 
Complications Attributable to the Use of rhBMP-2 Inside the Femoral Ring Allograft 
during Anterior Lumbar Interbody Fusion 
 
 We read with great interest the prospective analysis of interbody fusion rates by Slosar 
et al. [1] in which the exceptionally excellent results concerning the use of femoral ring 
allografts (FRA) with rhBMP-2 during anterior lumbar interbody fusion (ALIF) in addition 
with posterior pedicle screw fixation were reported. Namely, the rhBMP-2 group had a 100% 
fusion rate in all levels attempted (n=103), there were no complications attributable to the use 
of rhBMP-2 and no osteolysis or fragmentations of the allografts were observed. But, there 
was no mention of the subsidence which is defined as a fusion device sinking into one or both 
of the adjacent vertebral bodies [2] and end-plate erosions. 
 On the other side, Vaidya et al. [3] who used machined allograft spacers centrally 
filled with rhBMP-2 and additional posterior pedicle screw fixation during ALIF and also had 
100% fusion rate, found that 70% (14 of 20) of levels had signs of early lucency and 
underwent significant (> 10%) graft subsidence of a mean of 27% (13% to 42%). CT scans 
obtained from patients who received allograft/rhBMP-2 revealed two phenomena that may 
have contributed to subsidence. First, early lucency and incorporation of the allograft were 
noted, which may have resulted in a loss of structural support. Secondly, there was significant 
end-plate erosion in each rhBMP-2 case, an appearance that was not evident in patients 
treated without rhBMP-2.  
 End-plate erosions have been observed by CT during the first months of follow up in 3 
of 4 published studies concerning the use of FRA or similarly shaped allografts and rhBMP-2 
during ALIF [3-5] with [3,4] or without additional posterior instrumentation [5]. The only 
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study, beside the one of Slosar et al., which didn’t report end-plate erosion, was the case 
report by Lee et al. [6]. It was even expected as the CT was not used during the follow up. By 
the way, Lee et al. reported about histological analysis of a displaced femoral ring allograft 
spacer filled with rhBMP-2 soaked collagen sponge in a patient who also had additional 
posterior instrumentation 6 months after the surgery 
 The total doses of rhBMP-2 used per level of fusion were similar among mentioned 
studies (from 2 mg to 4,2 mg) (Joon Y. Lee, MD, written communication, September, 2007) 
[3,4,6] including Slosar et al. who used 3 mg of rhBMP-2 [1]. Only Pradhan et al. used higher 
dose of rhBMP-2 per level of fusion, i.e. 12 mg (Ben B. Pradhan, MD, MSE, written 
communication, September, 2007) [5]. 
 As the subsidence and end-plate erosion have not been mentioned at all in the entire 
manuscript of Slosar et al. [1], not even as possibilities of unanticipated adverse events related 
to the use of rhBMP-2, it is probable that authors have not been aware of these disorders at the 
time. The probability was confirmed when an overlooked subsidence of FRA allograft 6 
months following surgery at Figure 1 and 2 was noticed in the study of Slosar et al. (Figure 1) 
[1]. In the light of the presented findings, we kindly ask the authors to evaluate once again the 
CT scans from the patients involved in the study obtained 6 months after the operation 
concerning the subsidence and end-plate erosions and to inform reading audience about the 
results.  
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Figure Legend 
 
Figure 1. From the Slosar et al study. The arrows point the overlooked subsidence of femoral 
ring allograft into vertebral body 6 months following surgery, A) anterior view, B) lateral 
view. 
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